Oxygen News and Research

RSS

Zinc supplementation bolsters repurposed antivirals against SARS-CoV-2

A new preprint reports the efficacy of two repurposed drugs that could be useful against SARS-CoV-2 when supplemented with zinc.

2 Feb 2021

ACE2 agonist C21 relieves respiratory difficulty in COVID-19

A new study describes a pilot study on the efficacy of a molecule called C21, which enhances the activity of the angiotensin-converting enzyme 2 (ACE2), the host cell receptor that facilitates viral entry.

2 Feb 2021

Could ultra-low dose radiotherapy treat COVID-19-related pneumonia?

Researchers at the Department of Radiation Oncology, La Milagrosa Hospital, GenesisCare, Madrid, Spain, showed the potential benefit of treating COVID-19 pneumonia with ultra-low doses of radiotherapy.

2 Feb 2021

New COVID-19 variant identified in Brazilian Amazon spreads faster

A new variant of the virus that causes COVID-19, identified in Brazil, is likely more transmissible than its parent strain because of mutations in the spike protein, according to researchers.

1 Feb 2021

Researchers explore rapid outbreak of COVID-19 in U.S. detention facility

To assess the transmission of SARS-CoV-2 in a detention facility experiencing a COVID-19 outbreak, researchers at the U.S. Centers for Disease Control and Prevention (CDC) conducted testing for detained individuals in six quarantined dormitories at various time points.

1 Feb 2021

Groundbreaking therapy may provide a new treatment modality for biofilm infections in foot ulcers

A new £1.7m project to explore using plasma jets and antimicrobial dressings to treat debilitating - and potentially deadly - wound infections launches today.

1 Feb 2021

Study finds high bleeding risk in a sub-group of COVID-19 patients

The human body strives to keep itself in homeostasis, or balance. When blood clots are created, the body's innate response is to break the clots down to prevent significant health problems from arising.

1 Feb 2021

Colchicine may have therapeutic potential against COVID-19

A new study describes the results of colchicine in mitigating the inflammatory storm associated with COVID-19, and thus preventing a percentage of severe and critical cases.

1 Feb 2021

Complication of severe SARS-CoV-2 pneumonia results in persistent cortical blindness: Case report

A study recently published in the journal Cureus has described a case report of a coronavirus disease 2019 (COVID-19) patient who presented with pneumonia, posterior reversible encephalopathy syndrome (PRES), and persistent cortical blindness. A detailed clinical presentation of the patient is provided in the report.

31 Jan 2021

Lung mechanics and hypoxemia in COVID-19 patients with ARDS

To better understand how low blood oxygen level, or hypoxemia, and lung compliance varies in COVIDARDS and how they relate to disease outcomes, researchers developed a dataset of using more than 11,000 COVID-19 patients admitted to the hospital. A research paper published on the medRxiv* preprint server reports their results.

31 Jan 2021

DSMB recommends continuation of Phase 2/3 study of opaganib for severe COVID-19

RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced that the independent Data Safety Monitoring Board (DSMB) for the global Phase 2/3 study of opaganib in patients with severe COVID-19, unanimously recommended to continue the study following a pre-scheduled futility review of unblinded efficacy data from the first 135 patients treated in the study and safety data from the first 175 patients.

30 Jan 2021

Optimizing the structure of drug delivery systems can help target cancer cells

The main culprit in cancer is healthy cells that have gone rogue and acquire the ability to divide uncontrollably.

28 Jan 2021

Researchers identify a gene variant linked to cerebral small vessel disease and stroke

Researchers at Lund University in Sweden believe they have identified a gene variant that can cause cerebral small vessel disease and stroke. The study is published in Neurology Genetics.

28 Jan 2021

COVID-19 patients in high-altitude ICUs had improved survival in case study

A team of researchers in Ecuador and the U.K. found that high altitudes may be linked to improved COVID-19 survival – particularly among patients with no comorbidities.

28 Jan 2021

UVA receives $4.4 million federal grant to expand Interactive Home Monitoring program

A three-year, $4.4 million Federal Communications Commission grant will enable UVA Health to expand its Interactive Home Monitoring care for patients with serious and chronic conditions, including COVID-19 and diabetes.

27 Jan 2021

Baby blues: First-time parents blindsided by ‘the birthday rule’ and a $207,455 NICU bill

In the nine months leading up to her due date, Kayla Kjelshus and her husband, Mikkel, meticulously planned for their daughter's arrival.

27 Jan 2021

Biliverdin shields SARS-CoV-2 from host antibody response, study finds

A team of international scientists has recently revealed that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) interacts with two heme metabolites, bilirubin and biliverdin, to escape the antibody-mediated host immune responses.

27 Jan 2021

Remdesivir, given to half of hospitalized covid patients in U.S., is big win for Gilead — boosted by taxpayers

It was the end of April — just as the U.S. confirmed its millionth covid-19 case and 50,000 deaths — when White House adviser Dr. Anthony Fauci announced "highly significant" news about a drug called remdesivir.

27 Jan 2021

Hyperinflammatory conditions drive gender differences in COVID-19 severity and mortality

Recently researchers from India analyzed gender differences in COVID-19-related hyperinflammatory conditions resulting in mortality in Indian patients. The study is published on the preprint server, medRxiv*.

25 Jan 2021

Marine microalgae could be the solution to world's meat protein shortage

Marine microalgae-based cellular agriculture is a promising new way to sustainably produce plant-based 'meat' and healthy 'superfoods' for the future.

22 Jan 2021

Oxygen News and Research

Zinc supplementation bolsters repurposed antivirals against SARS-CoV-2

ACE2 agonist C21 relieves respiratory difficulty in COVID-19

Could ultra-low dose radiotherapy treat COVID-19-related pneumonia?

New COVID-19 variant identified in Brazilian Amazon spreads faster

Researchers explore rapid outbreak of COVID-19 in U.S. detention facility

Groundbreaking therapy may provide a new treatment modality for biofilm infections in foot ulcers

Study finds high bleeding risk in a sub-group of COVID-19 patients

Colchicine may have therapeutic potential against COVID-19

Complication of severe SARS-CoV-2 pneumonia results in persistent cortical blindness: Case report

Lung mechanics and hypoxemia in COVID-19 patients with ARDS

DSMB recommends continuation of Phase 2/3 study of opaganib for severe COVID-19

Optimizing the structure of drug delivery systems can help target cancer cells

Researchers identify a gene variant linked to cerebral small vessel disease and stroke

COVID-19 patients in high-altitude ICUs had improved survival in case study

UVA receives $4.4 million federal grant to expand Interactive Home Monitoring program

Baby blues: First-time parents blindsided by ‘the birthday rule’ and a $207,455 NICU bill

Biliverdin shields SARS-CoV-2 from host antibody response, study finds

Remdesivir, given to half of hospitalized covid patients in U.S., is big win for Gilead — boosted by taxpayers

Hyperinflammatory conditions drive gender differences in COVID-19 severity and mortality

Marine microalgae could be the solution to world's meat protein shortage

Oxygen Measurement eBook - Easily Understand Dissolved Oxygen Measurement eBook

Latest eBooks

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Driving innovation in Korean drug development

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC